tiprankstipranks
Trending News
More News >
New Providence Acquisition Corp. III Class A (NPAC)
NASDAQ:NPAC
US Market

New Providence Acquisition Corp. III Class A (NPAC) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
New Providence Acquisition Corp. III Class A
$10.26
$394.08M
-1.35%
Bayview Acquisition Corp Class A
$11.75
$40.73M
294.49
9.81%
Roma Green Finance Limited
$1.94
$115.56M
-14.49
148.75%
FibroBiologics, Inc.
$0.24
$17.71M
-0.52
-90.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
Alto Neuroscience, Inc.
$19.88
$617.60M
-8.01
361.25%
9 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.35
$48.82M
-3.91
-70.02%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NPAC
New Providence Acquisition Corp. III Class A
10.26
-0.09
-0.87%
BAYA
Bayview Acquisition Corp Class A
11.75
1.05
9.81%
ROMA
Roma Green Finance Limited
1.99
1.19
148.75%
FBLG
FibroBiologics, Inc.
0.24
-2.12
-89.83%
ANRO
Alto Neuroscience, Inc.
19.88
15.57
361.25%
TELO
Telomir Pharmaceuticals, Inc.
1.46
-3.41
-70.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts